Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.0760 (1.77%) ($6.8800 - $7.2000) on Fri. Nov. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.73% (three month average) | RSI | 58 | Latest Price | $7.0760(1.77%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES advances 6.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(8%) UNG(8%) IGOV(7%) FIVG(4%) ICLN(4%) | Factors Impacting EYES price | EYES will decline at least -1.865% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.865% (StdDev 3.73%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $7.07(0.08%) | 10 Day Moving Average | $6.83(3.6%) | 20 Day Moving Average | $6.66(6.25%) | To recent high | -7.9% | To recent low | 21.9% | Market Cap | $2.26b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |